Cargando…

The effect of TGF-β(1) polymorphisms on pulmonary disease progression in patients with cystic fibrosis

BACKGROUND: Transforming Growth Factor-β(1) (TGF-β(1)) is a genetic modifier in patients with cystic fibrosis (CF). Several single nucleotide polymorphisms (SNPs) of TGF-β(1) are associated with neutrophilic inflammation, lung fibrosis and loss of pulmonary function. AIM: The aim of this study was t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trojan, T., Alejandre Alcazar, Miguel A., Fink, G., Thomassen, J. C., Maessenhausen, M. V., Rietschel, E., Schneider, P. M., van Koningsbruggen-Rietschel, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080196/ https://www.ncbi.nlm.nih.gov/pubmed/35525938 http://dx.doi.org/10.1186/s12890-022-01977-1

Ejemplares similares

Reduced neutrophil elastase inhibitor elafin and elevated transforming growth factor-β(1) are linked to inflammatory response in sputum of cystic fibrosis patients with Pseudomonas aeruginosa
por: Thomassen, Jan C., et al.
Publicado: (2021)

Getting Near to “Closing the Gap” in the Pediatric Age Group for the First Personalized Treatment of Cystic Fibrosis
por: van Koningsbruggen-Rietschel, Silke
Publicado: (2021)

Identification of Critical Windows of Metabolic Programming of Metabolism and Lung Function in Male Offspring of Obese Dams
por: Dinger, Katharina, et al.
Publicado: (2020)

Impact of COVID-19 on people with cystic fibrosis
por: Colombo, Carla, et al.
Publicado: (2020)

Diabetes in Cystic Fibrosis: Multicenter Screening Results Based on Current Guidelines
por: Scheuing, Nicole, et al.
Publicado: (2013)

From the infant to the geriatric patient—Strategies for inhalation therapy in asthma and chronic obstructive pulmonary disease
por: Hagmeyer, Lars, et al.
Publicado: (2023)

Early-onset obesity dysregulates pulmonary adipocytokine/insulin signaling and induces asthma-like disease in mice
por: Dinger, Katharina, et al.
Publicado: (2016)

Surfactant Protein A in Cystic Fibrosis: Supratrimeric Structure and Pulmonary Outcome
por: Griese, Matthias, et al.
Publicado: (2012)

Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures
por: van Koningsbruggen-Rietschel, Silke, et al.
Publicado: (2021)

High Variability in Oral Glucose Tolerance among 1,128 Patients with Cystic Fibrosis: A Multicenter Screening Study
por: Scheuing, Nicole, et al.
Publicado: (2014)

Sequential analysis of surfactant, lung function and inflammation in cystic fibrosis patients
por: Griese, Matthias, et al.
Publicado: (2005)

Inhibition of TGF-β Signaling and Decreased Apoptosis in IUGR-Associated Lung Disease in Rats
por: Alejandre Alcázar, Miguel Angel, et al.
Publicado: (2011)

433: Rationale and design of an international multicenter prospective study to evaluate serologic immune responses to SARS-CoV-2 infection in persons living with cystic fibrosis: The CAR-CF study
por: Hernandez, R., et al.
Publicado: (2021)

Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study
por: van Koningsbruggen-Rietschel, Silke, et al.
Publicado: (2020)

2045 The role of TGFβ in driving early cystic fibrosis lung disease
por: Kramer, Elizabeth L., et al.
Publicado: (2018)

SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network
por: van Koningsbruggen-Rietschel, Silke, et al.
Publicado: (2020)

P062 Impact of the SARS-CoV-2 pandemic on clinical trials in the ECFS-CTN during 2020
por: Van Koningsbruggen-Rietschel, S., et al.
Publicado: (2021)

BARD1 mediates TGF-β signaling in pulmonary fibrosis
por: André, Pierre-Alain, et al.
Publicado: (2015)

Optimal control of TGF-β to prevent formation of pulmonary fibrosis
por: Bahram Yazdroudi, Fateme, et al.
Publicado: (2022)

TNF gene polymorphisms in cystic fibrosis patients: contribution to the disease progression
por: Shmarina, Galina, et al.
Publicado: (2013)

Study on the association between TGF-β1 and liver fibrosis in patients with hepatic cystic echinococcosis
por: Tian, Fengming, et al.
Publicado: (2020)

Relative Roles of TGF-β and IGFBP-5 in Idiopathic Pulmonary Fibrosis
por: Sureshbabu, A., et al.
Publicado: (2011)

TGF-β1: Gentlemanly orchestrator in idiopathic pulmonary fibrosis (Review)
por: Ye, Zhimin, et al.
Publicado: (2021)

Severe Human Bocavirus Infection, Germany
por: Körner, Robert Walter, et al.
Publicado: (2011)

Maternal and perinatal obesity induce bronchial obstruction and pulmonary hypertension via IL-6-FoxO1-axis in later life
por: Selle, Jaco, et al.
Publicado: (2022)

PKM2 promotes pulmonary fibrosis by stabilizing TGF-β1 receptor I and enhancing TGF-β1 signaling
por: Gao, Shaoyan, et al.
Publicado: (2022)

Role of MicroRNAs in TGF-β Signaling Pathway-Mediated Pulmonary Fibrosis
por: Kang, Hara
Publicado: (2017)

The Role of TGF-β Signaling in Lung Cancer Associated with Idiopathic Pulmonary Fibrosis
por: Saito, Akira, et al.
Publicado: (2018)

Tranilast Inhibits Pulmonary Fibrosis by Suppressing TGFβ/SMAD2 Pathway
por: Kato, Motoyasu, et al.
Publicado: (2020)

Syndecan-4 Inhibits the Development of Pulmonary Fibrosis by Attenuating TGF-β Signaling
por: Tanino, Yoshinori, et al.
Publicado: (2019)

Myeloid Fbxw7 Prevents Pulmonary Fibrosis by Suppressing TGF-β Production
por: He, Jia, et al.
Publicado: (2022)

COVID-19: Immunohistochemical Analysis of TGF-β Signaling Pathways in Pulmonary Fibrosis
por: Vaz de Paula, Caroline Busatta, et al.
Publicado: (2021)

The Role of TGF-β Receptors in Fibrosis
por: Nakerakanti, Sashidhar, et al.
Publicado: (2012)

Losartan ameliorates TGF-β1–induced CFTR dysfunction and improves correction by cystic fibrosis modulator therapies
por: Kim, Michael D., et al.
Publicado: (2022)

The Microbiome in Cystic Fibrosis Pulmonary Disease
por: Françoise, Alice, et al.
Publicado: (2020)

Progressive Scoliosis in a Child with Cystic Fibrosis
por: Castner, Lauren M., et al.
Publicado: (2019)

The Dynamics of Disease Progression in Cystic Fibrosis
por: Adler, Frederick R., et al.
Publicado: (2016)

Pulmonary aspiration in preschool children with cystic fibrosis
por: Clarke, D., et al.
Publicado: (2018)

Gene Therapy Progress and Prospects: Cystic fibrosis
por: Griesenbach, U, et al.
Publicado: (2002)

Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis
por: Lee, Chang-Min, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_87jfb7av318du5h3gihk3ova06